Schwab Charles Investment Management Inc. boosted its stake in shares of Catalent Inc (NASDAQ:CTLT) by 14.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 836,121 shares of the company’s stock after acquiring an additional 105,622 shares during the period. Schwab Charles Investment Management Inc. owned 0.67% of Catalent worth $29,348,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA increased its stake in Catalent by 1.2% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 10,909 shares of the company’s stock worth $309,000 after acquiring an additional 130 shares during the period. Aperio Group LLC increased its stake in Catalent by 0.8% during the 2nd quarter. Aperio Group LLC now owns 23,088 shares of the company’s stock worth $810,000 after acquiring an additional 190 shares during the period. Capstone Asset Management Co. increased its stake in Catalent by 2.3% during the 2nd quarter. Capstone Asset Management Co. now owns 10,130 shares of the company’s stock worth $356,000 after acquiring an additional 230 shares during the period. Advantus Capital Management Inc increased its stake in Catalent by 3.0% during the 1st quarter. Advantus Capital Management Inc now owns 15,972 shares of the company’s stock worth $452,000 after acquiring an additional 468 shares during the period. Finally, State Treasurer State of Michigan increased its stake in Catalent by 1.0% during the 1st quarter. State Treasurer State of Michigan now owns 50,700 shares of the company’s stock worth $1,436,000 after acquiring an additional 500 shares during the period.

WARNING: This story was originally posted by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.dailypolitical.com/2017/09/14/schwab-charles-investment-management-inc-buys-105622-shares-of-catalent-inc-ctlt.html.

A number of equities analysts have commented on the company. BidaskClub upgraded Catalent from a “sell” rating to a “hold” rating in a research note on Wednesday, August 16th. Zacks Investment Research upgraded Catalent from a “sell” rating to a “buy” rating and set a $39.00 price objective on the stock in a research note on Tuesday, July 4th. Piper Jaffray Companies restated a “buy” rating and set a $45.00 price objective on shares of Catalent in a research note on Tuesday, August 29th. Wells Fargo & Company restated an “outperform” rating and set a $39.00 price objective (up previously from $30.00) on shares of Catalent in a research note on Thursday, August 31st. Finally, Jefferies Group LLC restated a “hold” rating and set a $38.00 price objective (up previously from $35.00) on shares of Catalent in a research note on Tuesday, August 29th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $36.80.

Catalent Inc (CTLT) opened at 40.59 on Thursday. The stock has a 50 day moving average price of $36.52 and a 200 day moving average price of $33.34. Catalent Inc has a 52 week low of $21.83 and a 52 week high of $42.22. The company has a market cap of $5.08 billion and a price-to-earnings ratio of 46.66.

Catalent (NASDAQ:CTLT) last posted its earnings results on Monday, August 28th. The company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.08. The firm had revenue of $616.90 million for the quarter, compared to the consensus estimate of $547.48 million. Catalent had a return on equity of 16.95% and a net margin of 4.88%. The business’s quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.52 earnings per share. On average, equities analysts forecast that Catalent Inc will post $1.61 earnings per share for the current year.

In other Catalent news, SVP Christine Dolan sold 1,594 shares of the stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $38.75, for a total transaction of $61,767.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

About Catalent

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Institutional Ownership by Quarter for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.